Dolby Laboratories (DLB)

Profitability ratios

Return on sales

Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019
Gross profit margin 88.97% 88.72% 88.35% 88.27% 88.26% 88.02% 88.38% 88.43% 88.73% 89.30% 89.62% 89.75% 89.85% 88.81% 88.59% 88.53% 87.39% 87.39% 87.16% 87.04%
Operating profit margin 20.28% 16.55% 14.79% 14.67% 16.60% 19.14% 21.58% 16.98% 16.48% 17.44% 18.32% 21.74% 26.88% 26.36% 25.43% 26.58% 18.83% 20.17% 19.28% 19.25%
Pretax margin 24.33% 20.55% 18.41% 17.92% 19.16% 21.11% 23.25% 18.10% 17.18% 18.04% 18.86% 22.43% 27.08% 26.69% 25.99% 27.33% 20.61% 21.97% 21.15% 21.32%
Net profit margin 20.56% 16.87% 15.00% 14.70% 15.44% 17.03% 18.96% 14.83% 14.68% 15.91% 17.14% 20.52% 24.21% 23.11% 24.89% 25.23% 19.91% 20.89% 17.73% 16.71%

Dolby Laboratories has demonstrated a consistently high gross profit margin, averaging around 88% over the past five years. This indicates the company's ability to effectively manage production costs and generate profits on its products and services.

In terms of operating profit margin, Dolby has shown some variability, with fluctuations between 14% and 26% over the same period. While there have been some periods of lower profitability, the company has generally maintained a healthy operating profit margin, showcasing its operational efficiency.

The pretax margin for Dolby has also exhibited fluctuations, ranging from 17% to 27% over the past five years. Despite some variability, the company has been able to effectively manage its pre-tax income in relation to its total revenue, indicating sound financial management practices.

Dolby's net profit margin has shown a similar trend to the other profitability ratios, with fluctuations between 15% and 25% over the past five years. This metric reflects the company's ability to generate profits after accounting for all expenses, showing consistency in delivering net income relative to total revenue.

Overall, Dolby Laboratories has maintained strong profitability ratios over the past five years, demonstrating efficient cost management and solid financial performance.


Return on investment

Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019
Operating return on assets (Operating ROA) 8.31% 7.01% 6.16% 6.40% 7.24% 8.19% 9.73% 7.64% 7.68% 7.53% 7.52% 8.70% 11.09% 10.66% 10.05% 10.81% 7.50% 8.26% 8.15% 8.19%
Return on assets (ROA) 8.42% 7.14% 6.25% 6.41% 6.73% 7.29% 8.55% 6.67% 6.84% 6.87% 7.04% 8.21% 9.99% 9.34% 9.84% 10.26% 7.93% 8.56% 7.50% 7.11%
Return on total capital 10.43% 8.57% 8.08% 8.68% 10.08% 11.50% 12.66% 9.80% 9.61% 9.28% 9.14% 10.59% 13.37% 12.92% 12.34% 13.43% 9.85% 10.76% 11.14% 11.26%
Return on equity (ROE) 10.57% 8.73% 7.86% 8.03% 8.52% 9.26% 10.31% 8.02% 8.20% 8.17% 8.29% 9.67% 11.94% 11.17% 11.81% 12.39% 9.51% 10.22% 9.34% 8.82%

Dolby Laboratories has shown stable and positive profitability ratios over the past years. The operating return on assets (Operating ROA) has ranged from 6.16% to 9.73%, with a recent value of 8.31% as of September 30, 2024. This indicates that the company is generating operating profits efficiently relative to its total assets.

The return on assets (ROA) has fluctuated between 6.14% and 10.26% over the same period, with the latest value at 8.42% as of September 30, 2024. This metric reflects how effectively the company is utilizing its assets to generate profits.

Return on total capital has varied between 8.08% and 13.43%, with a recent value of 10.43% as of September 30, 2024. This ratio demonstrates the overall return generated by the company's total capital, including both debt and equity.

Lastly, the return on equity (ROE) has ranged from 7.86% to 12.39% over the period, with the most recent figure at 10.57% as of September 30, 2024. ROE measures the return earned on the shareholders' equity and highlights how well the company is generating profits from the shareholders' investments.

Overall, Dolby Laboratories has maintained solid profitability metrics, indicating efficient asset utilization, effective capital management, and satisfactory returns to both equity and total capital providers.